Analyst Ratings for Verrica Pharmaceuticals (VRCA)
VRCA Rating Summary
VRCA Price Target Summary
- Highest: $20.00 (TD Cowen)
- Lowest: $17.00 (Brookline Capital Markets)
- Average: $18.67
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$18.67 (+251.5%)
* Over Last 12-Mos
Rating Score: 5.6 / 10
Percentile Rank: 59%
Avg. $ Target:
$18.67 (+251.5%)
* Over Last 12-Mos
Rating Score: 5.6 / 10
Percentile Rank: 59%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/18/2025 | Brookline Capital Markets | Kemp Dolliver | Upgrade | Buy (Hold) |
17.00 (N/A) |
8.60 (5.31) |
-38.26% | Details |
| 11/5/2025 | Lucid Capital Markets | Dev Prasad | New Coverage | Buy (N/A) |
19.00 (N/A) |
3.28 (5.31) |
61.89% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
